About RougeTx
RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Naarden, The Netherlands
Tracked Since
Oct 7, 2026
Web & Domain Identity
Official Website
rougetx.com
Domain Registered Date
May 22, 2024
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $58,000,000 · Series-A
Backed by Angelini Ventures, BioGeneration Ventures
- Milestone
Website domain registered
rougetx.com
Investors & Backers
Angelini Ventures
Auréa
BioGeneration Ventures
Epidarex Capital
European Investment Bank Group
Kerna Ventures
Kurma Partners
p53
ROM Utrecht Region
Vesalius Biocapital Partners
Funding History
Series-A equity
· Oct 6, 2026
Round backers: Angelini Ventures, BioGeneration Ventures, Auréa, Epidarex Capital, European Investment Bank Group, Kerna Ventures, Kurma Partners, p53, ROM Utrecht Region, Vesalius Biocapital Partners
$58,000,000 finsmes.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026